CA
BBNX

CoreCap Advisors’s Beta Bionics BBNX Stock Holding History

CoreCap Advisors’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2K Sell
1,095
-394
-26% -$4.69K ﹤0.01% 1868
2026
Q1 		$14.9K Buy
1,489
+1,108
+291% +$16.4K ﹤0.01% 1787
2025
Q4 		$11.6K Sell
381
-100
-21% -$2.67K ﹤0.01% 1909
2025
Q3 		$9.56K Sell
481
-388
-45% -$6.82K ﹤0.01% 1955
2025
Q2 		$12.7K Buy
869
+309
+55% +$4.37K ﹤0.01% 1779
2025
Q1 		$6.85K Buy
+560
New +$10.4K ﹤0.01% 1979

Other funds holding BBNX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IWM
Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

CoreCap Advisors's BBNX Position: Q2 2026 in Review

CoreCap Advisors reduced its Beta Bionics (BBNX) stake by 26% in Q2 2026, selling an estimated $4.69K and leaving 1,095 shares worth $17.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1868.

CoreCap Advisors first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. 19 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • CoreCap Advisors held 1,095 shares of Beta Bionics worth $17.2K as of Q2 2026.
  • CoreCap Advisors sold 394 Beta Bionics shares in Q2 2026, an estimated $4.69K.
  • Beta Bionics made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1868 holding.
  • CoreCap Advisors first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • 19 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.